BAX EBITDA | BAXTER INTERNATIONAL INC.

BAXTER INTERNATIONAL INC. (BAX) EBITDA

2026-06-30: Basis Reported; EBITDA $456.00M*; Operating income $217.00M; Depreciation and amortization $239.00M*.
2026-03-31: Basis Reported; EBITDA $303M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$489M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $409.00M*; Operating income $172.00M; Depreciation and amortization $237.00M*.

Complete source-backed ebitda history.

Available history: 2013-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$456.00M*	$217.00M	$239.00M*	$2.96B	15.41%*	(m)	$285.00M*	$1.93B	$129.00M	$735.00M	$23.00M
2026-03-31	Reported	$303M	(m)	(m)	(m)	11.22%	(m)	$213.00M	$1.81B	$139.00M	$728.00M	$11.00M
2025-12-31	Reported	-$489M	(m)	(m)	(m)	-16.44%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$409.00M*	$172.00M	$237.00M*	$2.83B	14.43%*	(m)	$237.00M*	$1.89B	$118.00M	$708.00M	$172.00M
2025-06-30	Reported	$448.00M*	$191.00M	$257.00M*	$2.81B	15.94%*	(m)	$217.00M*	$1.82B	$134.00M	$718.00M	$11.00M
2025-03-31	Reported	$305M	(m)	(m)	(m)	11.62%	(m)	-$193.00M	$1.76B	$140.00M	$703.00M	-$67.00M
2024-12-31	Reported	-$190M	(m)	(m)	(m)	-6.90%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$409.00M*	$155.00M	$254.00M*	$2.70B	15.15%*	(m)	$253.00M*	$1.67B	$129.00M	$754.00M	$8.00M
2024-06-30	Reported	$406.00M*	$179.00M	$227.00M*	$2.69B	15.07%*	(m)	$115.00M*	$1.66B	$130.00M	$723.00M	$22.00M
2024-03-31	Reported	$386M	(m)	(m)	(m)	15.50%	(m)	$163.00M	$1.53B	$120.00M	$729.00M	$40.00M
2023-12-31	Reported	$568M	(m)	(m)	(m)	20.84%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$271.00M*	$179.00M	$92.00M*	$2.60B	10.43%*	(m)	$365.00M*	$1.54B	$133.00M	$744.00M	$27.00M
2023-06-30	Reported	$298.00M*	-$17.00M	$315.00M*	$2.59B	11.50%*	(m)	$351.00M*	$2.60B	$165.00M	$964.00M	$10.00M
2023-03-31	Reported	$442M	(m)	(m)	(m)	12.58%	(m)	$479.00M	$2.24B	$164.00M	$995.00M	$14.00M
2022-12-31	Reported	-$294M	(m)	(m)	(m)	41.76%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$2.55B*	-$2.88B	$331.00M*	$3.61B	-70.63%*	(m)	$290.00M*	$2.56B	$151.00M	$941.00M	-$54.00M
2022-06-30	Reported	$607.00M*	$264.00M	$343.00M*	$3.59B	16.89%*	(m)	$274.00M*	$2.22B	$148.00M	$970.00M	$34.00M
2022-03-31	Reported	$543M	(m)	(m)	(m)	14.65%	(m)	$208.00M	$2.36B	$150.00M	$1.05B	$21.00M
2021-12-31	Reported	$245M	(m)	(m)	(m)	8.52%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	$719.00M*	$513.00M	$206.00M*	$3.23B	22.29%*	(m)	$675.00M*	$1.91B	$129.00M	$680.00M	-$1.00M
2021-06-30	Reported	$646.00M*	$424.00M	$222.00M*	$3.10B	20.85%*	(m)	$477.00M*	$1.86B	$139.00M	$675.00M	$91.00M
2021-03-31	Reported	$607M	(m)	(m)	(m)	20.60%	(m)	$377.00M	$1.80B	$128.00M	$627.00M	$51.00M
2020-12-31	Reported	$619M	(m)	(m)	(m)	19.46%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	$679.00M*	$470.00M	$209.00M*	$2.97B	22.85%*	(m)	$510.00M*	$1.78B	$123.00M	$601.00M	$56.00M
2020-06-30	Reported	$533.00M*	$331.00M	$202.00M*	$2.72B	19.61%*	(m)	$374.00M*	$1.68B	$117.00M	$590.00M	$42.00M
2020-03-31	Reported	$608M	(m)	(m)	(m)	21.70%	(m)	$272.00M	$1.64B	$146.00M	$628.00M	$45.00M
2019-12-31	Reported	$745M	(m)	(m)	(m)	24.51%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	$698.00M*	$503.00M	$195.00M*	$2.85B	24.48%*	(m)	$701.00M*	$1.62B	$144.00M	$627.00M	$106.00M
2019-06-30	Reported	$543.00M*	$350.00M	$193.00M*	$2.83B	19.16%*	(m)	$446.00M*	$1.68B	$166.00M	$641.00M	$13.00M
2019-03-31	Reported	$575M	(m)	(m)	(m)	21.80%	(m)	$128.00M	$1.56B	$129.00M	$601.00M	$44.00M
2018-12-31	Reported	$576M	(m)	(m)	(m)	20.33%	(m)	(m)	$1.65B	$175.00M	$627.00M	$102.00M
2018-09-30	Reported	$586.00M*	$382.00M	$204.00M*	$2.76B	21.22%*	(m)	$476.00M*	$1.53B	$166.00M	$684.00M	-$146.00M
2018-06-30	Reported	$569.00M*	$377.00M	$192.00M*	$2.81B	20.23%*	(m)	$402.00M*	$1.59B	$172.00M	$676.00M	$63.00M
2018-03-31	Reported	$624M	(m)	(m)	(m)	23.31%	(m)	$430.00M	$1.57B	$141.00M	$633.00M	$46.00M
2017-12-31	Reported	$476M	(m)	(m)	(m)	17.02%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	$484.00M*	$300.00M	$184.00M*	$2.71B	17.88%*	(m)	$605.00M*	$1.58B	$150.00M	$680.00M	$42.00M
2017-06-30	Reported	$531.00M*	$347.00M	$184.00M*	$2.60B	20.38%*	(m)	$529.00M*	$1.47B	$155.00M	$630.00M	$42.00M
2017-03-31	Reported	$547M	(m)	(m)	(m)	22.10%	(m)	$189.00M	$1.43B	$127.00M	$564.00M	$55.00M
2016-12-31	Reported	$504M	(m)	(m)	(m)	19.05%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	$390.00M*	$186.00M	$204.00M*	(m)	(m)	(m)	$532.00M*	$1.49B	$159.00M	$726.00M	$1.00M
2016-06-30	Reported	$274.00M*	$68.00M	$206.00M*	(m)	(m)	(m)	$742.00M*	$1.61B	$195.00M	$709.00M	$6.00M
2016-03-31	Reported	$377M	(m)	(m)	(m)	15.87%	(m)	-$333.00M	$1.41B	$136.00M	$641.00M	-$58.00M
2015-12-31	Reported	$344M	(m)	(m)	(m)	13.22%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	$308.00M*	$92.00M	$216.00M*	(m)	(m)	(m)	$255.00M*	$1.45B	$148.00M	$794.00M	-$35.00M
2015-09-30	Reported	(m)	$92.00M	(m)	(m)	(m)	(m)	(m)	$1.45B	$148.00M	$794.00M	-$35.00M
2015-06-30	Reported	$277.00M*	$87.00M	$190.00M*	(m)	(m)	(m)	$696.00M*	$1.45B	$151.00M	$783.00M	$34.00M
2015-03-31	Reported	$279M	(m)	(m)	(m)	11.61%	(m)	$96.00M	$1.38B	$143.00M	$784.00M	$14.00M
2014-12-31	Reported	$391M	(m)	(m)	(m)	14.02%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	$320.00M*	$217.00M	$103.00M*	(m)	(m)	(m)	$914.00M*	$1.52B	$149.00M	$827.00M	$27.00M
2014-03-31	Reported	(m)	(m)	$236.00M	(m)	(m)	(m)	$559.00M	$1.96B	$309.00M	$910.00M	$146.00M
2013-03-31	Reported	(m)	(m)	$183.00M	(m)	(m)	(m)	$386.00M	$1.69B	$246.00M	$795.00M	$141.00M
2012-03-31	Reported	(m)	(m)	$175.00M	(m)	(m)	(m)	$446.00M	$1.67B	$269.00M	$752.00M	$144.00M
2011-03-31	Reported	(m)	(m)	$158.00M	(m)	(m)	(m)	$371.00M	$1.61B	$214.00M	$716.00M	$154.00M
2010-03-31	Reported	(m)	(m)	$166.00M	(m)	(m)	(m)	$279.00M	$1.88B	$227.00M	$683.00M	$172.00M
2009-03-31	Reported	(m)	(m)	$148.00M	(m)	(m)	(m)	$237.00M	$1.34B	$212.00M	$611.00M	$119.00M

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$673M	(m)	(m)	(m)	5.99%	(m)	$845.00M	$7.87B	$518.00M	$2.89B	$395.00M
2024-12-31	Reported	$1.01B	(m)	(m)	(m)	9.51%	(m)	$1.02B	$6.65B	$590.00M	$2.97B	$37.00M
2023-12-31	Reported	$1.69B	(m)	(m)	(m)	16.32%	(m)	$1.73B	$6.21B	$518.00M	$2.95B	$61.00M
2022-12-31	Reported	-$1.77B	(m)	(m)	(m)	-17.63%	(m)	$1.21B	$6.51B	$450.00M	$3.10B	-$135.00M
2021-12-31	Reported	$2.22B	(m)	(m)	(m)	18.25%	(m)	$2.22B	$7.43B	$531.00M	$2.85B	$83.00M
2020-12-31	Reported	$2.44B	(m)	(m)	(m)	20.89%	(m)	$1.87B	$7.09B	$521.00M	$2.47B	$182.00M
2019-12-31	Reported	$2.56B	(m)	(m)	(m)	22.54%	(m)	$2.10B	$6.60B	$595.00M	$2.54B	-$41.00M
2019-09-30	Rolling	(m)	$1.63B*	(m)	$11.16B*	(m)	(m)	(m)	$6.51B*	$614.00M*	$2.50B*	$265.00M*
2019-06-30	Rolling	(m)	$1.51B*	(m)	$11.07B*	(m)	(m)	(m)	$6.42B*	$636.00M*	$2.55B*	$13.00M*
2019-03-31	Rolling	(m)	$1.53B*	(m)	$11.04B*	(m)	(m)	(m)	$6.33B*	$642.00M*	$2.59B*	$63.00M*
2018-12-31	Reported	$2.36B	(m)	(m)	(m)	21.22%	(m)	$2.02B	$6.34B	$654.00M	$2.62B	$65.00M
2018-12-31	Rolling	(m)	$1.58B*	(m)	$11.10B*	(m)	(m)	(m)	$6.34B*	$654.00M*	$2.62B*	$65.00M*
2017-12-31	Reported	$2.04B	(m)	(m)	(m)	19.26%	(m)	$1.71B	$6.11B	$615.00M	$2.63B	$491.00M
2016-12-31	Reported	$1.55B	(m)	(m)	(m)	15.20%	(m)	$1.65B	$6.05B	$646.00M	$2.73B	-$12.00M
2015-12-31	Reported	$1.21B	(m)	(m)	(m)	12.12%	(m)	$1.77B	$5.78B	$587.00M	$3.03B	$35.00M
2014-12-31	Reported	$1.45B	(m)	(m)	(m)	13.51%	(m)	$3.21B	$6.14B	$610.00M	$3.31B	$33.00M
2013-12-31	Reported	$1.13B	(m)	(m)	(m)	12.02%	(m)	$3.20B	$5.25B	$582.00M	$3.08B	$60.00M
2012-12-31	Reported	(m)	(m)	$712.00M	(m)	(m)	(m)	$3.11B	$6.80B	$1.08B	$3.28B	$555.00M
2011-12-31	Reported	(m)	(m)	$670.00M	(m)	(m)	(m)	$2.82B	$6.85B	$946.00M	$3.15B	$553.00M
2010-12-31	Reported	(m)	(m)	$685.00M	(m)	(m)	(m)	$3.00B	$6.88B	$915.00M	$2.91B	$463.00M
2009-12-31	Reported	(m)	(m)	$638.00M	(m)	(m)	(m)	$2.91B	$6.04B	$917.00M	$2.73B	$519.00M
2008-12-31	Reported	(m)	(m)	$631.00M	(m)	(m)	(m)	$2.52B	$6.22B	$868.00M	$2.70B	$437.00M
2007-12-31	Reported	(m)	(m)	$581.00M	(m)	(m)	(m)	$2.31B	$5.74B	$760.00M	$2.52B	$407.00M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Penumbra Inc (PEN)	United States	$12.596B	77.33
GLOBUS MEDICAL INC (GMED)	United States	$9.977B	20.03
INSULET CORP (PODD)	United States	$9.420B	28.12
Solventum Corp (SOLV)	United States	$15.085B	9.16
GLAUKOS Corp (GKOS)	United States	$9.135B	-43.73
MiniMed Group, Inc. (MMED)	United States	$5.748B	-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)	United States	$5.212B	28.44
TELEFLEX INC (TFX)	United States	$5.093B	-5.44
HAEMONETICS CORP (HAE)	United States	$4.821B	36.52
Heartflow, Inc. (HTFL)	United States	$4.225B